Please use this identifier to cite or link to this item:
|Title:||Angiopoietin-1 for myocardial angiogenesis: A comparison between delivery strategies|
|Authors:||Ye, L. |
|Source:||Ye, L., Toh, W.C., Haider, H.K., Jiang, S., Tan, R.S., Ge, R., Sim, E.K.W. (2007). Angiopoietin-1 for myocardial angiogenesis: A comparison between delivery strategies. European Journal of Heart Failure 9 (5) : 458-465. ScholarBank@NUS Repository. https://doi.org/10.1016/j.ejheart.2006.10.022|
|Abstract:||We compare the effectiveness of direct adenoviral angiopoietin-1 (Ad-Ang-1) injection with transplantation of skeletal myoblasts (SkMs) over-expressing angiopoietin-1 (Ang-1) for angiogenic response and improvement of heart function in an experimental porcine model of myocardial infarction (MI). Methods: Ad-Ang-1 was used for intramyocardial injection or transduction of SkMs. Three weeks after coronary artery ligation in 32 female pigs, animals were grouped to receive multiple intramyocardial injections of DMEM without cells (group-1; n = 7), or containing 3 × 108 Lac-z labelled SkMs transduced with Ad-Null vector carrying no gene (group-2; n = 7), or 1 × 1010 PFU Ad-Ang-1 (group-3; n = 9), or 3 × 108 Lac-z labelled SkMs transduced with Ad-Ang-1 (group-4; n = 9). The animals were immunosuppressed for 6-weeks. After euthanasia, their heart tissue was processed for histological studies. Results: Extensive survival of Lac-z positive SkMs was observed in and around the infarct 6 and 12-weeks after transplantation. Fluorescent immunostaining for vWF-VIII at 6-weeks revealed increased blood vessel density (× 100) in group-4 (p < 0.05) as compared with other groups. Regional blood flow (ml/g/min) in the peri-infarct area was improved in group-4 (2.7; p < 0.05) as compared with group-1 (1.2 ± 0.1), group-2 (1.1 ± 0.4) and group-3 (1.7 ± 0.1) at 6-weeks. Similarly, ejection fraction was significantly higher in group-4 (49.2 ± 5.9%, p = 0.03) as compared with group-1 (36.8 ± 3%) at 6 weeks. Conclusion: SkMs mediated Ang-1 delivery is associated with improved angiogenic response, regional myocardial perfusion and heart function as compared with direct Ad-Ang-1 administration. © 2006 European Society of Cardiology.|
|Source Title:||European Journal of Heart Failure|
|Appears in Collections:||Staff Publications|
Show full item record
Files in This Item:
There are no files associated with this item.
checked on Mar 7, 2018
WEB OF SCIENCETM
checked on Feb 5, 2018
checked on Mar 11, 2018
Items in DSpace are protected by copyright, with all rights reserved, unless otherwise indicated.